Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967473 · ClinicalTrials.gov registry record · NA
ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)
A NA study of Bilateral Cataract, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00967473: Completed NA study of Bilateral Cataract, sponsored by Alcon Research.
NCT00967473 is a NA study of Bilateral Cataract that has completed, run by Alcon Research. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00967473, a NA study of Bilateral Cataract, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe rates of spatial distortions related to intraocular lens (IOL) misalignment for ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 when implanted bilaterally into the capsular bag following phacoemulsification in adult patients with bilateral cataract and regular corneal astigmatism. Subjects were implanted with the Model SN60T9 in the first operative (study) eye and either Model SN60T9 or Model SN60T8 in the second operative eye.
Primary Outcome
Rates of spatial distortions were evaluated by use of the Visual Distortion Questionnaire (VDQ). The VDQ evaluates the rate \& frequency of subjects' experiences with potential visual distortions. The fewer the patients that report visual distortions, the better. The VDQ is a binocular assessment, therfore the subject will use both eyes to evaluate visual distortions.
Conditions Studied
Interventions
- DEVICE ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.
Study Locations (1)
Texas
- Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT00967473 record still lists
NCT00967473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Bilateral Cataract appearing as the primary indexed condition, and to 1 intervention - of which ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8. is the first listed.
NCT00967473 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00967473 about?
NCT00967473 is a clinical study titled "ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)". The purpose of this study is to describe rates of spatial distortions related to intraocular lens (IOL) misalignment for ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 when implanted bilaterally into the capsular bag following phacoemulsification in adult patients with bilateral cataract and r...
What is the current status of trial NCT00967473?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-08. Estimated completion is 2010-05.
What conditions does trial NCT00967473 study?
This clinical trial studies the following conditions: Bilateral Cataract.
What interventions are being tested in trial NCT00967473?
The interventions under investigation include: ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8. (DEVICE).
Who is sponsoring clinical trial NCT00967473?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00967473 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00967473's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia